title: [Transitional cell carcinoma of the ureter and cyclophosphamide: apropos of a case].
abstract: The authors present a case of transitional cell carcinoma of the ureter in a patient treated by cyclophosphamide-based chemotherapy and radiotherapy for Hodgkin's disease. In the light of this case, they review the eight previously reported cases of cyclophosphamide-induced ureteric tumours.
authors.affiliation: Service d'Urologie, Centre Hospitalier Universitaire de Sherbrooke, Québec, Canada.
authors.forename: Y
authors.initials: Y
authors.lastname: Ponsot
authors.forename: J G
authors.initials: JG
authors.lastname: Guerin
authors.forename: M
authors.initials: M
authors.lastname: Carmel
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002273:Carcinogens / Q000009:adverse effects; D002295:Carcinoma, Transitional Cell / Q000473:pathology*; D003520:Cyclophosphamide / Q000009:adverse effects*; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000473:pathology*; D014516:Ureteral Neoplasms / Q000473:pathology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002273:Carcinogens; D003520:Cyclophosphamide
vernacular_title: Carcinome transitionnel de l'uretère et cyclophosphamide: a propos d'un cas.